Diffuse Fibrotic Lung Disease

• Status: Completed
• Trial end date: 1983-01-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the effects of cyclophosphamide compared with prednisone, dapsone, or high-dose intermittent 'pulse' therapy with methylprednisolone in patients with idiopathic pulmonary fibrosis. Also, to evaluate the use of intermittent, short-term, high-dose intravenous corticosteroids in patients with sarcoidosis. There were actually four separate clinical trials.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Cyclophosphamide; Dapsone; Prednisone

Criteria

No eligibility criteria